Rogue stem cell clinics
Cell therapies hold significant promise for the treatment of injured or diseased musculoskeletal tissues. However, despite advances in research, there is growing concern about the increasing number of clinical centres around the world that are making unwarranted claims or are performing risky biolog...
Gespeichert in:
| Veröffentlicht in: | Journal of bone and joint surgery. British volume 2020-02, Vol.102-B (2), p.148-154 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 154 |
|---|---|
| container_issue | 2 |
| container_start_page | 148 |
| container_title | Journal of bone and joint surgery. British volume |
| container_volume | 102-B |
| creator | Murray, Iain R Chahla, Jorge Frank, Rachel M Piuzzi, Nicolas S Mandelbaum, Bert R Dragoo, Jason L |
| description | Cell therapies hold significant promise for the treatment of injured or diseased musculoskeletal tissues. However, despite advances in research, there is growing concern about the increasing number of clinical centres around the world that are making unwarranted claims or are performing risky biological procedures. Such providers have been known to recommend, prescribe, or deliver so called 'stem cell' preparations without sufficient data to support their true content and efficacy. In this annotation, we outline the current environment of stem cell-based treatments and the strategies of marketing directly to consumers. We also outline the difficulties in the regulation of these clinics and make recommendations for best practice and the identification and reporting of illegitimate providers. Cite this article:
2020;102-B(2):148-154. |
| doi_str_mv | 10.1302/0301-620X.102B2.BJJ-2019-1104.R1 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7002842</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2350352620</sourcerecordid><originalsourceid>FETCH-LOGICAL-c538t-40f93c356dd253d9399462f045a6a2421f60a570f319579bfbcd0be2134315323</originalsourceid><addsrcrecordid>eNpdkUtLw0AURgdRbKldu5OCm24S7507k2Q2oi2-SkEoCu6GPCY1JU1qJhH89yb2gTqbGbiHj_nuYWyM4CIBvwICdDwOby4Cn3B3Mps5HFA5iCDcBR6xPgehHCEgON6_SYkeG1q7gvYEgCjwlPWIAyhBQZ-dL8plY0a2NutRbPJ8FOdZkcX2jJ2kYW7NcHcP2Ov93cv00Zk_PzxNb-dOLCmoHQGpopiklyRcUqJIKeHxFIQMvZALjqkHofQhJVTSV1EaxQlEhiMJQkmcBux6m7tporVJYlPUVZjrTZWtw-pLl2Gm_06K7F0vy0_tA_BAdAHjXUBVfjTG1nqd2a5JWJiysZqTBJK83VuLXv5DV2VTFW29lhIKJXi-11I3WyquSmsrkx4-g6A7EboToTsR-keEbkXoToTuROgFthEXv0sdAvZrp2_WuIHZ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2349150676</pqid></control><display><type>article</type><title>Rogue stem cell clinics</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Murray, Iain R ; Chahla, Jorge ; Frank, Rachel M ; Piuzzi, Nicolas S ; Mandelbaum, Bert R ; Dragoo, Jason L</creator><creatorcontrib>Murray, Iain R ; Chahla, Jorge ; Frank, Rachel M ; Piuzzi, Nicolas S ; Mandelbaum, Bert R ; Dragoo, Jason L ; Members of the Biologics Association</creatorcontrib><description>Cell therapies hold significant promise for the treatment of injured or diseased musculoskeletal tissues. However, despite advances in research, there is growing concern about the increasing number of clinical centres around the world that are making unwarranted claims or are performing risky biological procedures. Such providers have been known to recommend, prescribe, or deliver so called 'stem cell' preparations without sufficient data to support their true content and efficacy. In this annotation, we outline the current environment of stem cell-based treatments and the strategies of marketing directly to consumers. We also outline the difficulties in the regulation of these clinics and make recommendations for best practice and the identification and reporting of illegitimate providers. Cite this article:
2020;102-B(2):148-154.</description><identifier>ISSN: 2049-4394</identifier><identifier>EISSN: 2049-4408</identifier><identifier>DOI: 10.1302/0301-620X.102B2.BJJ-2019-1104.R1</identifier><identifier>PMID: 32009438</identifier><language>eng</language><publisher>England: British Editorial Society of Bone & Joint Surgery</publisher><subject><![CDATA[Ambulatory Care Facilities - legislation & jurisprudence ; Ambulatory Care Facilities - standards ; Annotation ; Consumer Product Safety - legislation & jurisprudence ; Consumer Product Safety - standards ; Direct-to-Consumer Advertising - legislation & jurisprudence ; Direct-to-Consumer Advertising - standards ; Direct-to-Consumer Advertising - trends ; Humans ; Marketing of Health Services - legislation & jurisprudence ; Marketing of Health Services - standards ; Marketing of Health Services - trends ; Musculoskeletal Diseases - surgery ; Patient Safety - legislation & jurisprudence ; Patient Safety - standards ; Practice Guidelines as Topic - standards ; Stem Cell Transplantation - legislation & jurisprudence ; Stem Cell Transplantation - standards ; Stem Cell Transplantation - trends ; Stem cells ; United Kingdom ; United States]]></subject><ispartof>Journal of bone and joint surgery. British volume, 2020-02, Vol.102-B (2), p.148-154</ispartof><rights>2020 The British Editorial Society of Bone & Joint Surgery</rights><rights>2019 Author(s) et al</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c538t-40f93c356dd253d9399462f045a6a2421f60a570f319579bfbcd0be2134315323</citedby><cites>FETCH-LOGICAL-c538t-40f93c356dd253d9399462f045a6a2421f60a570f319579bfbcd0be2134315323</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32009438$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Murray, Iain R</creatorcontrib><creatorcontrib>Chahla, Jorge</creatorcontrib><creatorcontrib>Frank, Rachel M</creatorcontrib><creatorcontrib>Piuzzi, Nicolas S</creatorcontrib><creatorcontrib>Mandelbaum, Bert R</creatorcontrib><creatorcontrib>Dragoo, Jason L</creatorcontrib><creatorcontrib>Members of the Biologics Association</creatorcontrib><title>Rogue stem cell clinics</title><title>Journal of bone and joint surgery. British volume</title><addtitle>Bone Joint J</addtitle><description>Cell therapies hold significant promise for the treatment of injured or diseased musculoskeletal tissues. However, despite advances in research, there is growing concern about the increasing number of clinical centres around the world that are making unwarranted claims or are performing risky biological procedures. Such providers have been known to recommend, prescribe, or deliver so called 'stem cell' preparations without sufficient data to support their true content and efficacy. In this annotation, we outline the current environment of stem cell-based treatments and the strategies of marketing directly to consumers. We also outline the difficulties in the regulation of these clinics and make recommendations for best practice and the identification and reporting of illegitimate providers. Cite this article:
2020;102-B(2):148-154.</description><subject>Ambulatory Care Facilities - legislation & jurisprudence</subject><subject>Ambulatory Care Facilities - standards</subject><subject>Annotation</subject><subject>Consumer Product Safety - legislation & jurisprudence</subject><subject>Consumer Product Safety - standards</subject><subject>Direct-to-Consumer Advertising - legislation & jurisprudence</subject><subject>Direct-to-Consumer Advertising - standards</subject><subject>Direct-to-Consumer Advertising - trends</subject><subject>Humans</subject><subject>Marketing of Health Services - legislation & jurisprudence</subject><subject>Marketing of Health Services - standards</subject><subject>Marketing of Health Services - trends</subject><subject>Musculoskeletal Diseases - surgery</subject><subject>Patient Safety - legislation & jurisprudence</subject><subject>Patient Safety - standards</subject><subject>Practice Guidelines as Topic - standards</subject><subject>Stem Cell Transplantation - legislation & jurisprudence</subject><subject>Stem Cell Transplantation - standards</subject><subject>Stem Cell Transplantation - trends</subject><subject>Stem cells</subject><subject>United Kingdom</subject><subject>United States</subject><issn>2049-4394</issn><issn>2049-4408</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkUtLw0AURgdRbKldu5OCm24S7507k2Q2oi2-SkEoCu6GPCY1JU1qJhH89yb2gTqbGbiHj_nuYWyM4CIBvwICdDwOby4Cn3B3Mps5HFA5iCDcBR6xPgehHCEgON6_SYkeG1q7gvYEgCjwlPWIAyhBQZ-dL8plY0a2NutRbPJ8FOdZkcX2jJ2kYW7NcHcP2Ov93cv00Zk_PzxNb-dOLCmoHQGpopiklyRcUqJIKeHxFIQMvZALjqkHofQhJVTSV1EaxQlEhiMJQkmcBux6m7tporVJYlPUVZjrTZWtw-pLl2Gm_06K7F0vy0_tA_BAdAHjXUBVfjTG1nqd2a5JWJiysZqTBJK83VuLXv5DV2VTFW29lhIKJXi-11I3WyquSmsrkx4-g6A7EboToTsR-keEbkXoToTuROgFthEXv0sdAvZrp2_WuIHZ</recordid><startdate>20200201</startdate><enddate>20200201</enddate><creator>Murray, Iain R</creator><creator>Chahla, Jorge</creator><creator>Frank, Rachel M</creator><creator>Piuzzi, Nicolas S</creator><creator>Mandelbaum, Bert R</creator><creator>Dragoo, Jason L</creator><general>British Editorial Society of Bone & Joint Surgery</general><general>The British Editorial Society of Bone & Joint Surgery</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20200201</creationdate><title>Rogue stem cell clinics</title><author>Murray, Iain R ; Chahla, Jorge ; Frank, Rachel M ; Piuzzi, Nicolas S ; Mandelbaum, Bert R ; Dragoo, Jason L</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c538t-40f93c356dd253d9399462f045a6a2421f60a570f319579bfbcd0be2134315323</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Ambulatory Care Facilities - legislation & jurisprudence</topic><topic>Ambulatory Care Facilities - standards</topic><topic>Annotation</topic><topic>Consumer Product Safety - legislation & jurisprudence</topic><topic>Consumer Product Safety - standards</topic><topic>Direct-to-Consumer Advertising - legislation & jurisprudence</topic><topic>Direct-to-Consumer Advertising - standards</topic><topic>Direct-to-Consumer Advertising - trends</topic><topic>Humans</topic><topic>Marketing of Health Services - legislation & jurisprudence</topic><topic>Marketing of Health Services - standards</topic><topic>Marketing of Health Services - trends</topic><topic>Musculoskeletal Diseases - surgery</topic><topic>Patient Safety - legislation & jurisprudence</topic><topic>Patient Safety - standards</topic><topic>Practice Guidelines as Topic - standards</topic><topic>Stem Cell Transplantation - legislation & jurisprudence</topic><topic>Stem Cell Transplantation - standards</topic><topic>Stem Cell Transplantation - trends</topic><topic>Stem cells</topic><topic>United Kingdom</topic><topic>United States</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Murray, Iain R</creatorcontrib><creatorcontrib>Chahla, Jorge</creatorcontrib><creatorcontrib>Frank, Rachel M</creatorcontrib><creatorcontrib>Piuzzi, Nicolas S</creatorcontrib><creatorcontrib>Mandelbaum, Bert R</creatorcontrib><creatorcontrib>Dragoo, Jason L</creatorcontrib><creatorcontrib>Members of the Biologics Association</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of bone and joint surgery. British volume</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Murray, Iain R</au><au>Chahla, Jorge</au><au>Frank, Rachel M</au><au>Piuzzi, Nicolas S</au><au>Mandelbaum, Bert R</au><au>Dragoo, Jason L</au><aucorp>Members of the Biologics Association</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Rogue stem cell clinics</atitle><jtitle>Journal of bone and joint surgery. British volume</jtitle><addtitle>Bone Joint J</addtitle><date>2020-02-01</date><risdate>2020</risdate><volume>102-B</volume><issue>2</issue><spage>148</spage><epage>154</epage><pages>148-154</pages><issn>2049-4394</issn><eissn>2049-4408</eissn><abstract>Cell therapies hold significant promise for the treatment of injured or diseased musculoskeletal tissues. However, despite advances in research, there is growing concern about the increasing number of clinical centres around the world that are making unwarranted claims or are performing risky biological procedures. Such providers have been known to recommend, prescribe, or deliver so called 'stem cell' preparations without sufficient data to support their true content and efficacy. In this annotation, we outline the current environment of stem cell-based treatments and the strategies of marketing directly to consumers. We also outline the difficulties in the regulation of these clinics and make recommendations for best practice and the identification and reporting of illegitimate providers. Cite this article:
2020;102-B(2):148-154.</abstract><cop>England</cop><pub>British Editorial Society of Bone & Joint Surgery</pub><pmid>32009438</pmid><doi>10.1302/0301-620X.102B2.BJJ-2019-1104.R1</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 2049-4394 |
| ispartof | Journal of bone and joint surgery. British volume, 2020-02, Vol.102-B (2), p.148-154 |
| issn | 2049-4394 2049-4408 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7002842 |
| source | MEDLINE; Alma/SFX Local Collection |
| subjects | Ambulatory Care Facilities - legislation & jurisprudence Ambulatory Care Facilities - standards Annotation Consumer Product Safety - legislation & jurisprudence Consumer Product Safety - standards Direct-to-Consumer Advertising - legislation & jurisprudence Direct-to-Consumer Advertising - standards Direct-to-Consumer Advertising - trends Humans Marketing of Health Services - legislation & jurisprudence Marketing of Health Services - standards Marketing of Health Services - trends Musculoskeletal Diseases - surgery Patient Safety - legislation & jurisprudence Patient Safety - standards Practice Guidelines as Topic - standards Stem Cell Transplantation - legislation & jurisprudence Stem Cell Transplantation - standards Stem Cell Transplantation - trends Stem cells United Kingdom United States |
| title | Rogue stem cell clinics |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T21%3A48%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Rogue%20stem%20cell%20clinics&rft.jtitle=Journal%20of%20bone%20and%20joint%20surgery.%20British%20volume&rft.au=Murray,%20Iain%20R&rft.aucorp=Members%20of%20the%20Biologics%20Association&rft.date=2020-02-01&rft.volume=102-B&rft.issue=2&rft.spage=148&rft.epage=154&rft.pages=148-154&rft.issn=2049-4394&rft.eissn=2049-4408&rft_id=info:doi/10.1302/0301-620X.102B2.BJJ-2019-1104.R1&rft_dat=%3Cproquest_pubme%3E2350352620%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2349150676&rft_id=info:pmid/32009438&rfr_iscdi=true |